![]() Local commissioners and providers of healthcare have a responsibility to enable the guideline to be applied when individual professionals and people using services wish to use it. It is not mandatory to apply the recommendations, and the guideline does not override the responsibility to make decisions appropriate to the circumstances of the individual, in consultation with them and their families and carers or guardian.Īll problems (adverse events) related to a medicine or medical device used for treatment or in a procedure should be reported to the Medicines and Healthcare products Regulatory Agency using the Yellow Card Scheme. When exercising their judgement, professionals and practitioners are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or the people using their service. The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. This guideline updates and replaces NICE guideline CG180 (June 2014). This guideline was commissioned by NICE and developed in partnership with the Royal College of Physicians (RCP). People with atrial fibrillation, their families and carers.initial management of stroke and atrial fibrillation.personalised package of care and information.preventing and managing postoperative atrial fibrillation.assessment of stroke and bleeding risks.This guideline includes new and updated recommendations on: See the MHRA advice on warfarin and other anticoagulants – monitoring of patients during the COVID-19 pandemic, which includes reports of supratherapeutic anticoagulation with warfarin. The recommendations in this guideline were developed before the COVID-19 pandemic. On 30 June 2021, we amended our recommendation on using the ORBIT score to assess bleeding risk to reinstate the previous link to an appropriate calculation tool, which was removed in error on 10 June 2021. It includes guidance on providing the best care and treatment for people with atrial fibrillation, including assessing and managing risks of stroke and bleeding. This guideline covers diagnosing and managing atrial fibrillation in adults.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |